SCHEMBL24634614

SCHEMBL24634614

CNC(=O)NC(c1cccnc1)c1cc(Cl)c2cccnc2c1O

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 5/20 0.68
SMN1; SMN2 Q16637 5/20 0.68
KMT2A Q03164 5/20 0.68
MEN1 O00255 4/20 0.68
NPC1 O15118 5/20 0.66
RAB9A P51151 5/20 0.66
HSP90AA1 P07900 4/20 0.66
L3MBTL1 Q9Y468 4/20 0.66
KDM4E B2RXH2 4/20 0.66
LMNA P02545 3/20 0.66
TDP1 Q9NUW8 2/20 0.66
ALDH1A1 P00352 1/20 0.66
MAPT P10636 1/20 0.66
POLB P06746 1/20 0.61
ADAMTS5 Q9UNA0 4/20 0.59
ALOX12 P18054 5/20 0.59
NCOA3 Q9Y6Q9 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30876598 1.00 HTT (0.68) HTTSMN1; SMN2KMT2AMEN1NPC1
SCHEMBL4039606 0.90 NPC1 (0.82) HTTSMN1; SMN2KMT2AMEN1NPC1
SCHEMBL29855987 0.90 NPC1 (0.82) HTTSMN1; SMN2KMT2AMEN1NPC1
Hydrochloric Acid SCHEMBL4040420 0.89 NPC1 (0.80) HTTSMN1; SMN2KMT2AMEN1NPC1
SCHEMBL30876646 0.87 ALOX12 (0.77) HTTSMN1; SMN2KMT2AMEN1NPC1
SCHEMBL24634616 0.87 ALOX12 (0.77) HTTSMN1; SMN2KMT2AMEN1NPC1
SCHEMBL24634757 0.87 HTT (0.67) HTTSMN1; SMN2KMT2AMEN1NPC1
SCHEMBL30876628 0.87 HTT (0.67) HTTSMN1; SMN2KMT2AMEN1NPC1
SCHEMBL24634759 0.86 KDM1A (0.72) HTTSMN1; SMN2KMT2AMEN1NPC1
SCHEMBL30876584 0.86 KDM1A (0.72) HTTSMN1; SMN2KMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240124419-A1 SMALL MOLECULE INHIBITORS OF GRP78 AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2024-04-18 US disclosed
WO-2022169834-A2 SMALL MOLECULE INHIBITORS OF GRP78 AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2022-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240124419-A1 SMALL MOLECULE INHIBITORS OF GRP78 AND USES THEREOF HSPA5, HSPA2, PSMG3 HTT 2113/4885SMN1; SMN2 2825/4885KMT2A 4365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.